Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells

被引:78
作者
Cao, Wei [1 ]
Bover, Laura [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA
关键词
dendritic cells; plasmacytoid dendritic cells; ILT7; BST2; dendritic cell receptors; receptor signal; TOLL-LIKE RECEPTORS; MHC CLASS-I; INTERFERON-PRODUCING CELLS; INHIBITS TLR9-MEDIATED ACTIVATION; IFN-ALPHA PRODUCTION; SINGLE-STRANDED RNA; CUTTING EDGE; T-CELLS; NKG2D RECEPTOR; ANTIGEN PRESENTATION;
D O I
10.1111/j.0105-2896.2009.00867.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plasmacytoid dendritic cells (pDCs) are specialized dendritic cells (DCs) that produce large amounts of type I interferon (IFN) after Toll-like receptor (TLR) activation. Human pDCs preferentially express immunoglobulin-like transcript 7 (ILT7; LILRA4), which couples with a signaling adapter to activate a prominent immunoreceptor tyrosine-based activation motif (ITAM)-mediated signaling pathway. ILT7 protein directly binds to and can be activated by bone marrow stromal cell antigen 2 (BST2; CD317) protein, the expression of which is found on cells pre-exposed to IFN or on the surface of human cancer cells. The interaction between ILT7 and BST2 functions to assure an appropriate TLR response by pDCs during viral infection and likely participates in pDC-tumor crosstalk. Two opposing modes of receptor-mediated regulatory mechanisms work jointly to fine tune the innate immunity of pDCs.
引用
收藏
页码:163 / 176
页数:14
相关论文
共 162 条
[11]   Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus [J].
Blanco, P ;
Palucka, AK ;
Gill, M ;
Pascual, V ;
Banchereau, J .
SCIENCE, 2001, 294 (5546) :1540-1543
[12]   A cell-surface molecule selectively expressed on murine natural interferon-producing cells that blocks secretion of interferon-alpha [J].
Blasius, A ;
Vermi, W ;
Krug, A ;
Facchetti, F ;
Cella, M ;
Colonna, M .
BLOOD, 2004, 103 (11) :4201-4206
[13]   Siglec-H is an IPC-specific receptor that modulates type IIFN secretion through DAP12 [J].
Blasius, AL ;
Cella, M ;
Maldonado, J ;
Takai, T ;
Colonna, M .
BLOOD, 2006, 107 (06) :2474-2476
[14]   Bone marrow stromal cell antigen 2 is a specific marker of type IIFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation [J].
Blasius, Amanda L. ;
Giurisato, Emanuele ;
Celia, Marina ;
Schreiber, Robert D. ;
Shaw, Andrey S. ;
Colonna, Marco .
JOURNAL OF IMMUNOLOGY, 2006, 177 (05) :3260-3265
[15]   Use of genetic profiling in leprosy to discriminate clinical forms of the disease [J].
Bleharski, JR ;
Li, HY ;
Meinken, C ;
Graeber, TG ;
Ochoa, MT ;
Yamamura, M ;
Burdick, A ;
Sarno, EN ;
Wagner, M ;
Röllinghoff, M ;
Rea, TH ;
Colonna, M ;
Stenger, S ;
Bloom, BR ;
Eisenberg, D ;
Modlin, RL .
SCIENCE, 2003, 301 (5639) :1527-1530
[16]   LIR9, an immunoglobulin-superfamily-activating receptor, is expressed as a transmembrane and as a secreted molecule [J].
Borges, L ;
Kubin, M ;
Kuhlman, T .
BLOOD, 2003, 101 (04) :1484-1486
[17]   The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling [J].
Brinkmann, Melanie M. ;
Spooner, Eric ;
Hoebe, Kasper ;
Beutler, Bruce ;
Ploegh, Hidde L. ;
Kim, You-Me .
JOURNAL OF CELL BIOLOGY, 2007, 177 (02) :265-275
[18]   The LILR family: modulators of innate and adaptive immune pathways in health and disease [J].
Brown, D ;
Trowsdale, J ;
Allen, R .
TISSUE ANTIGENS, 2004, 64 (03) :215-225
[19]   Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis [J].
Cai, Dongqing ;
Cao, Jie ;
Li, Zhen ;
Zheng, Xin ;
Yao, Yao ;
Li, Wanglin ;
Yuan, Ziqiang .
BMC CANCER, 2009, 9
[20]   Comparison of chimpanzee and human leukocyte Ig-like receptor genes reveals framework and rapidly evolving genes [J].
Canavez, F ;
Young, NT ;
Guethlein, LA ;
Rajalingam, R ;
Khakoo, SI ;
Shum, BP ;
Parham, P .
JOURNAL OF IMMUNOLOGY, 2001, 167 (10) :5786-5794